<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="preprint">
<?all-math-mml yes?>
<?use-mml?>
<?origin ukpmcpa?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">bioRxiv</journal-id>
<journal-title-group>
<journal-title>bioRxiv : the preprint server for biology</journal-title>
</journal-title-group>
<issn pub-type="ppub"/>
</journal-meta>
<article-meta>
<article-id pub-id-type="manuscript">EMS98309</article-id>
<article-id pub-id-type="doi">10.1101/2020.10.12.336099</article-id>
<article-id pub-id-type="archive">PPR225568</article-id>
<article-version article-version-type="publisher-id">2</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular characterization of SARS-CoV-2 from Bangladesh: Implications in genetic diversity, possible origin of the virus, and functional significance of the mutations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rahman</surname>
<given-names>Marufur</given-names>
<prefix>Md.</prefix>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kader</surname>
<given-names>Shirmin Bintay</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rizvi</surname>
<given-names>S M Shahriar</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Centre for Medical Biotechnology, Management Information System, Directorate General of Health Services</aff>
<aff id="A2">
<label>2</label>International Centre for Diarrhoeal Disease Research, Bangladesh</aff>
<aff id="A3">
<label>3</label>Communicable Disease Control, Directorate General of Health Services</aff>
<author-notes>
<corresp id="CR1">Corresponding Author: Md. Marufur Rahman, <email>dr.marufrhmn@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>15</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="preprint">
<day>13</day>
<month>10</month>
<year>2020</year>
</pub-date>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">
<license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nd/4.0/">CC BY-ND 4.0 International license</ext-link>.</license-p>
</license>
</permissions>
<abstract>
<p id="P1">In a try to understand the pathogenesis, evolution and epidemiology of the SARS-CoV-2 virus, scientists from all over the world are tracking its genomic changes in real-time. Genomic studies can be helpful in understanding the disease dynamics. We have downloaded 324 complete and near complete SARS-CoV-2 genomes submitted in GISAID database from Bangladesh which were isolated between 30 March to 7 September, 2020. We then compared these genomes with Wuhan reference sequence and found 4160 mutation events including 2253 missense single nucleotide variations, 38 deletions and 10 insertions. The C&gt;T nucleotide change was most prevalent (41% of all muations) possibly due to selective mutation pressure to reduce CpG sites to evade CpG targeted host immune response. The most frequent mutation that occurred in 98% isolates was 3037C&gt;T which is a synonymous change that almost always accompanied 3 other mutations that include 241C&gt;T, 14408C&gt;T (P323L in RdRp) and 23403A&gt;G (D614G in spike protein). The P323L was reported to increase mutation rate and D614G is associated with increased viral replication and currently most prevalent variant circulating all over the world. We identified multiple missense mutations in B-cell and T-cell predicted epitope regions and/or PCR target regions (including R203K and G204R that occurred in 86% of the isolates) that may impact immunogenicity and/or RT-PCR based diagnosis. Our analysis revealed 5 large deletion events in ORF7a and ORF8 gene products that may be associated with less severity of the disease and increased viral clearance. Our phylogeny analysis identified most of the isolates belonged to the Nextstrain clade 20B (86%) and GISAID clade GR (88%). Most of our isolates shared common ancestors either directly with European countries or jointly with middle eastern countries as well as Australia and India. Interestingly, the 19B clade (GISAID S clade) was unique to Chittagong which was originally prevalent in China. This reveals possible multiple introduction of the virus in Bangladesh via different routes. Hence more genome sequencing and analysis with related clinical data is needed to interpret functional significance and better predict the disease dynamics that may be helpful for policy makers to control the COVID-19 pandemic in Bangladesh.</p>
</abstract>
<kwd-group>
<kwd>SARS-CoV-2</kwd>
<kwd>Genome</kwd>
<kwd>mutation</kwd>
<kwd>phylogeny</kwd>
<kwd>COVID-19</kwd>
<kwd>Bangladesh</kwd>
<kwd>D614G</kwd>
<kwd>P323L</kwd>
<kwd>Spike protein</kwd>
<kwd>genome sequence</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Background</title>
<p id="P2">The world is suffering from COVID-19, a devastating pandemic caused by a novel coronavirus originating from Wuhan, China(<xref ref-type="bibr" rid="R1">1</xref>). Meanwhile, scientists from all over the world are trying to understand the virus better using various processes including genome sequencing. The first reported complete genome sequence was identified in January 3, 2020. (<xref ref-type="bibr" rid="R2">2</xref>). More than 141 thousand genomic sequences of SARS-CoV-2 has been submitted in the Global Initiative on Sharing All Influenza Data (GISAID) database (<xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref>).</p>
<p id="P3">The genomic sequences revealed that the length of the SARS-CoV-2 viral genome is ~30kb. The longest part of the genome at 5’ end encodes for orflab polyprotein whereas the rest of the genome consists of genes for encoding four structural proteins namely surface (S), envelope (E), membrane (M) and nucleocapsid (N), accessory proteins and other non-structural proteins (NSP) encoded by ORF3a, ORF6, ORF7a, ORF7b, ORF8 and ORF10 genes(<xref ref-type="bibr" rid="R5">5</xref>). Depending on amino acid changes Forster et. al. reported three central variants (A,B,C) of SARS-CoV-2 where A and C being the most common type in Europe and USA and B being the most common type in East Asia (<xref ref-type="bibr" rid="R6">6</xref>). Pachetti el. al. identified multiple mutation hotspot with geographic location specificity. They identified mutations in RNA dependent RNA polymerase (RdRp) gene which is important as some of the proposed drugs are targeting RdRp protein and mutations at in the gene may facilitate the virus to escape from those drugs (<xref ref-type="bibr" rid="R7">7</xref>). Yao et. al. identified pathogenic variations depending specific SNVs in the Spike glycoprotein (S) changing viral load and cytopathic effects upto 270 folds (<xref ref-type="bibr" rid="R8">8</xref>). Deletions in the viral genomes are also common phenomena and sometimes these are related to severity of the diseases (<xref ref-type="bibr" rid="R9">9</xref>–<xref ref-type="bibr" rid="R11">11</xref>). Still there is a lack of studies to integrate all the deletions in the whole genome of SARS-CoV-2 globally. This may contribute to understand the pathogenic dynamics of the virus over time. The genetic differences among SARS-CoV-2 strains from different location can be linked with their geographical distributions (<xref ref-type="bibr" rid="R12">12</xref>). The recent studies suggested that dry and cold climate can boost the spreading of the infections (<xref ref-type="bibr" rid="R13">13</xref>).</p>
<p id="P4">The clade and lineage nomenclature is rapidly changing. Specific combinations of 9 genetic markers shows 95% of the hCOV-19 data in GISAID can be further classified in major 6 clades named S, L, V, G, GH, GR (<xref ref-type="bibr" rid="R5">5</xref>). Initially the virus was classified into 2, then further into 3 super clades (<xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R7">7</xref>). The initial assessment of 3 clades indicates distinct geographic distribution (China, USA and Europe). A team of scientists has developed an open source bioinformatics and visualization toolkit named Nextstrain (www.nextstrain.org) for real-time tracking of pathogen evaluation including SARS-CoV-2 (<xref ref-type="bibr" rid="R8">8</xref>). Their clade nomenclature is different but supplementary to Rambaut et al. 2020 (<xref ref-type="bibr" rid="R9">9</xref>).</p>
<p id="P5">The virus was first reported in Bangladesh on March 8, 2020 as first 3 cases were identified at the Institute of Epidemiology and Disease Research, Dhaka. Currently the country is at the community spread stage and the total number of infected is about 379,738 with 5,555 reported deaths from COVID-19 till 12 October, 2020 (<xref ref-type="bibr" rid="R14">14</xref>,<xref ref-type="bibr" rid="R15">15</xref>).</p>
<p id="P6">It is important to get more sequences from all over the world which will help us for better understanding of the evolution pattern, disease dynamics, phylogeographic distribution of the clades, design drugs and vaccines etc. In this paper we tried to determine the phylogenetic relationship of Bangladeshi isolates with other isolates from around the world. This can help us to know about the travelling routes of the virus into our country and how it travelled in other parts of the world. We also tried to know the specific mutational differences in our isolates compared to the reference sequence and whether there is any clinico-pathological significance associated with those mutations.</p>
</sec>
<sec id="S2" sec-type="methods">
<title>Methods</title>
<sec id="S3">
<title>Local sequence retrieval</title>
<p id="P7">For retrieval of genome sequences from Bangladesh, we have searched in the GISAID database using search term “Bangladesh” as location. We have downloaded all the relevant sequences from search result in FASTA format and also downloaded patient status metadata, sequencing technology metadata and acknowledgement table separately (accessed on 30 August, 2020).</p>
</sec>
<sec id="S4">
<title>Mutation analysis</title>
<p id="P8">We have used Genome Detective Coronavirus Typing Tool version 1.13 and CoVsurver enabled by GISAID to analyse our query sequences in FASTA format (<xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref>). These tools are free of charge, online based bioinformatic tools that are validated to identify and reassemble novel corona virus isolates. Using these tools, we identified both nucleotide and amino acid mutations and similarities compared to SARS-CoV-2 reference sequence NC_045512 (NCBI) and EPI_ISL_402124 (GISAID).</p>
<p id="P9">For functional prediction of mutational changes, we have used two web based tools namely SIFT (Sorting Intolerant From Tolerant) and MutPred2 (<xref ref-type="bibr" rid="R18">18</xref>,<xref ref-type="bibr" rid="R19">19</xref>). We also have used USCS SARS-CoV-2 Genome Browser (https://genome.ucsc.edu/cgi-bin/hgGateway?db=wuhCor1) to align mutations along base position and functionally significant areas in the genome (<xref ref-type="bibr" rid="R20">20</xref>).(A support vector machine (SVM) based tool namely i-Mutant 3.0 was used for predicting the change of protein stability change and ΔΔG from specific mutations (<xref ref-type="bibr" rid="R21">21</xref>).</p>
</sec>
<sec id="S5">
<title>Phylogeny analysis</title>
<p id="P10">We have used open source bioinformatics visualization platform Nextstrain (nextstrain.org,) for phylogeny analysis of our sequences (<xref ref-type="bibr" rid="R22">22</xref>). Pairwise sequence alignment and clade assignment was done using web based Nextstrain tool Nextclade beta version 0.4.9 (<xref ref-type="bibr" rid="R23">23</xref>). The GISAID clade identification of the sequences was done using GISAID CoVsurver tool. Further detailed information of different clusters was derived from a preformed interactive web-based tree developed from a subsample of global sequences (~5000) by neighbour joining method in Nextstrain web interface (<ext-link ext-link-type="uri" xlink:href="https://nextstrain.org/ncov/global">https://nextstrain.org/ncov/global</ext-link>, date accessed on 30 August, 2020).</p>
</sec>
</sec>
<sec id="S6" sec-type="results">
<title>Results</title>
<sec id="S7">
<title>Mutation Analysis with functional significance</title>
<p id="P11">From GISAID database we have found 329 submissions from Bangladesh (accessed on 30 August, 2020). Out of the 329 submissions, 324 were complete/near genomes. Among the complete genomes, 102 were isolated from female patients, 220 were from male patients and for 2 isolates the gender was not reported. The age range of collected samples were between 8 days to 95 years and the median age was 38 years. The submissions came from a total of 9 laboratories and different sequencing platforms were used by different laboratories. A quality control (QC) analysis was done where 7 sequences were flagged as “bad” (private mutation cut-off was set at 20) and 6 sequences were reported to have more than 5 ambiguous mutations.</p>
<p id="P12">Variation analysis from 324 genome isolates revealed a total of 4160 mutation events out of which 4112 are Single Nucleotide Variations (SNVs), 38 deletions (in 30 isolates) and 10 insertions (in 10 isolates). Among the SNVs 2253 were missense mutations in coding regions, 1216 were synonymous mutations and rest were in non-coding part of the genome (<xref ref-type="table" rid="T1">Table 1</xref>). Among all the SNVs the most common change was C&gt;T (~41%) and the second most prevalent change was G&gt;A (~16%). There were 5 large deletions (&gt;50 nucleotide) among which three resulted in deletion of a large portion ORF7a gene and another two deleted the ORF8 gene. The highest number of mutation events (including all SNVs and indels) observed in one isolate (EPI_ISL_445217) was 59 and least was zero as one isolate (EPI_ISL_458133) was identical to the reference genome (NC_045512.3) with 99.4% genome coverage. The average number of mutation events was approximately 13 per isolate.</p>
<p id="P13">The most common mutation in non-coding region was 241C&gt;T, observed in 96% (312) isolates. The mutation with highest frequency (~98%) in coding region was 3037C&gt;T (synonymous) and 14408C&gt;T (missense) in ORF1ab gene, and 23403A&gt;G (missense) in S gene. The latter caused D614G amino acid change in the spike protein of the virus. Among the 19 missense SNVs that occurred more than 5 times, 12 were predicted to decrease the stability of their respective protein structure (DDG value less than -0.5kcal/mol) and six of the SNVs were predicted to alter protein function. Among these 19 frequent SNVs, 9 were in T-Cell epitope predicted regions and 5 were in B-Cell epitope predicted regions. The T592I mutation in ORF1ab polyprotein (NSP2) was strongly predicted for CD8+ T-Cell epitope that was also predicted for altered protein function. The P4715L, one of the highest frequent SNVs, occurred in the RNA dependent RNA polymerase (RdRp) region of ORF1ab polyprotein. Beside these, two of the high frequency (86%) SNVs (R203K and G204R) occurred in COVID-19 diagnostic RT-PCR target and B-Cell predicted epitope regions, of which the later was predicted to cause altered function of the nucleocapsid protein (<xref ref-type="fig" rid="F1">Figure-1</xref>). Further analysis revealed two SNVs (L3606F, H15Y) were predicted to cause altered ordered interface and altered transmembrane protein for ORF1ab polyprotein (NSP6) and Membrane (M) protein respectively where L3606F was predicted to cause gain of sulfation at Y360 position of NSP3 protein (<xref ref-type="table" rid="T2">Table 2</xref>).</p>
</sec>
<sec id="S8">
<title>Mutation analysis of S gene</title>
<p id="P14">A separate and detailed analysis of SARS-CoV-2 S gene was done and revealed a total of 530 mutation events among which 414 were missense events and 3 were single amino acid deletions. These mutation events comprised of 56 SNVs and 2 deletions where D614G was the mutation of highest frequency that occurred in 98% (315) isolates. Among the SNVs 35 were predicted to decrease protein stability (DDG less than or around -0.5kcal/mol), 8 were predicted to alter protein function, 18 were in predicted B-Cell epitope region and 26 were in T-Cell predicted epitope region. Individual analysis of these mutations with functional significance is shown in <xref ref-type="supplementary-material" rid="SD2">Supplementary Table 1</xref>. Three SNVs were found in the receptor binding domain of the spike protein but none of them was in the ACE2 receptor binding part of the protein (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="fig" rid="F3">3</xref>).</p>
</sec>
<sec id="S9">
<title>Phylogeny analysis</title>
<p id="P15">After phylogeny analysis we have found, our 324 isolates were distributed among all the nextstrain clades where 20B clade was the most frequent (86%) (<xref ref-type="fig" rid="F4">Figure 4</xref>). The 19B clade was unique to Chittagong (5 isolates) and one root clade 19A isolate was reported from Dhaka. There were 24 isolates for which the location data was unknown and only one isolate was found in 20C clade. We also have analysed clade distribution of our sequences according to GISAID nomenclature and found more than 96% of the isolates belonged to the G clade and its two major branches GH and GR clade. The common distinctive feature of these three clades is D614G mutation. About 88% of the sequences clustered in GR clade the distinctive feature of which is G204R mutation in the nucleocapsid protein. (<xref ref-type="fig" rid="F4">Figure 4</xref> and <xref ref-type="table" rid="T3">Table 3</xref>).</p>
<p id="P16">The overall analysis revealed most of the isolates shared common ancestors with European countries. A subsampled global phylogeny analysis revealed the largest cluster of Bangladeshi isolates shared common ancestor with some Australian isolates that were reported between mid-May to mid-July. Several other clusters were formed sharing common ancestors with countries including Senegal, Morocco, Egypt, Oman, Saudi Arabia, India, Srilanka, Zhenjiang (China), Portugal, Norway, Luxembourg, Bosnia and Herzegovina, England and Italy (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>,<xref ref-type="supplementary-material" rid="SD3">2</xref>,<xref ref-type="supplementary-material" rid="SD4">3</xref>).</p>
</sec>
</sec>
<sec id="S10" sec-type="discussion">
<title>Discussion</title>
<p id="P17">The current SARS-CoV-2 pandemic has changed the world in many ways bringing devastating effects on the society and environment yet we have seen some positive changes and one of which is increased collaboration of scientists and open source projects from all over the world. The collaborative efforts are making huge impact on research and evidence generation. In our study we have tried to gather data on genetic evolution and mutational impacts of SARS-CoV-2 that has been isolated and sequenced in Bangladesh. Our analysis revealed multiple introduction of the virus from different regions in our country as the phylogeny tree shows isolates closely related to different countries and regions of the world. Although most of the isolates were related to isolates from middle eastern and European countries, this can be explained as a lot of Bangladeshi migrant workers live in those countries including Saudi Arabia, Oman, Belgium and Italy. Many of these migrant workers came back to Bangladesh during first and second quarter of this year as number of COVID-19 cases were very high in those regions (<xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R27">27</xref>). Interestingly the largest cluster was formed around Australian isolates but going further back on the tree reveals last common ancestor was also related to the European isolates (Sweden and Switzerland). Hence the abundance of 20B clade is observed in Bangladesh unlike neighbouring India and Pakistan where Asian and North American Clades (19A, 19B, 20B) are more dominant (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<p id="P18">In our analysis we have found the most common single nucleotide change was C to T (~41%). This phenomenon was reported earlier by Biol et al. and can be explained by selective mutation pressure to reduce CpG sites in the presence of abundant human antiviral proteins including APOBEC3 and ZAP. The CpG sites are common targets of viral genome and can be recognized by TLRs that results in release of pro-inflammatory cytokines including type-I interferon, IL-6, IL-12 and TNF-α (<xref ref-type="bibr" rid="R28">28</xref>). As pro-inflammatory cytokines play key role in severe COVID-19 including lung tissue damage, the reducing CpG in SARS-CoV-2 may indicate this mutational change facilitates the viral replication but may also reduce disease severity due to less immune reaction through CpG targeted pathways (<xref ref-type="bibr" rid="R29">29</xref>). Inverse relation of disease severity with viral load has been reported in a recent study (<xref ref-type="bibr" rid="R30">30</xref>). Hence, we think further research is needed focusing the CpG suppression rate in SARS-CoV-2 and its relation with viral load and disease severity which may help designing more potent vaccine and therapeutics.</p>
<p id="P19">Large deletion events were observed among some of the isolates that resulted in deletion of most of ORF7a or ORF8 gene products. Three such deletions were between base position 27487 to 27552 (65 nucleotide), 27912 to 28256 (344 nucleotide) and 27472 to 27672 (200 nucleotide). Though these proteins are accessory proteins and not necessary for viral replication, ORF7a was found to interact with human ribosomal transport proteins MDN1 and HEATR3 (<xref ref-type="bibr" rid="R31">31</xref>). In SARS-CoV the ORF7a was reported to act as cellular translation inhibitor and apoptosis inducer (<xref ref-type="bibr" rid="R32">32</xref>). Hence deletion of ORF7a may not change viral replication but can alter disease severity by reducing the chance of ORF7a mediated apoptosis. Similar deletions was reported earlier from USA (<xref ref-type="bibr" rid="R33">33</xref>). On the other hand, ORF8 protein is least similar to its SARS-CoV homolog and reported to be associated with MHC-I downregulation that facilitates the virus for immune evasion from Cytotoxic T-Cells. This kind of immune evasion facilitates virus to replicate without getting detected by immune cells hence producing less symptoms. Similar mechanism of immune evasion is observed in some chronic infection causing viruses including HIV-1 and Kaposi Sarcoma associated Herpes Virus (KSHV).</p>
<p id="P20">This may be one of the reasons for the large number of asymptomatic patients, chronic viral shedding even after clinical cure and redetection of virus long after recovery (<xref ref-type="bibr" rid="R34">34</xref>). The ORF8 protein may be responsible for such manifestations and deletion of the protein may cause a disadvantage to the virus increasing more change of getting detected by the immune system and getting eliminated.</p>
<p id="P21">The 241C&gt;T mutation was one of the most frequent (96%) one we have observed in our study. This mutation occurred in 5’ UTR region, so it may not have any functional significance except for reducing CpG sites. Interestingly, this mutation always accompanied 3 other mutations in same isolates. Those mutations include 3037C&gt;T (98%), 14408C&gt;T (98%) and 23403A&gt;G (97%) where the latter two are non-synonymous mutations (P4715L in ORF1ab or P323L in RdRp and D614G in Spike protein). This co-occurrence of said mutations are not by chance rather a linkage disequilibrium that has been reported earlier by several studies (<xref ref-type="bibr" rid="R35">35</xref>–<xref ref-type="bibr" rid="R37">37</xref>). These co-mutations are primary features of GISAID G clade that started rising since February in Europe and now includes more than 70% of all SARS-CoV-2 sequences from all over the world (<xref ref-type="bibr" rid="R35">35</xref>). The high prevalence of these 4 mutations in Bangladesh also establishes stronger linkage with European isolates. The P323L mutation in RdRp is reported to be associated with increased mutation rate (<xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R39">39</xref>). Among all 4 mutations the D614G is most studied and reported. Though not in the receptor binding part of Spike protein, multiple studies reported that the D614G mutation provides the SARS-CoV-2 an evolutionary advantage for replication. Studies reported D614G mutation increases infectivity of the virus as it was found to be associated with higher viral load and higher infectious titre (<xref ref-type="bibr" rid="R40">40</xref>–<xref ref-type="bibr" rid="R42">42</xref>).</p>
<p id="P22">The D614 amino acid is located between S1 and S2 junction of spike protein. The cleavage of S1-S2 junction by host protease is crucial for entry into the host cell and multiple cleavage site enhances the fusion of SARS-CoV with host cell membrane (<xref ref-type="bibr" rid="R43">43</xref>). One study predicted D614G mutation introduces a novel protease (elastase) cleavage site that may enhance the fusion of viral envelop to the host cell membrane hence further facilitate viral RNA entry into the host cell (<xref ref-type="bibr" rid="R44">44</xref>). Studies identified the 614G variant of the virus can get more functional advantage in population with delC variant (rs35074065 site) of TMPRSS2 gene (<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R45">45</xref>). This variant is common in Europe, America and South Asia but extremely rare in East Asia according to 1000 Genome project data (<xref ref-type="bibr" rid="R46">46</xref>). This may explain the spread of D614G or G clade in mostly Europe, America and recently in South Asia. While some studies suggested that D614G mutation is associated with higher fatality rate (<xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R48">48</xref>), several other studies reported no significant association (<xref ref-type="bibr" rid="R41">41</xref>,<xref ref-type="bibr" rid="R49">49</xref>). Interestingly one study on US patients reported inverse relation of disease severity and duration with SARS-CoV-2 viral load (<xref ref-type="bibr" rid="R30">30</xref>). Considering these analyses it can be said that the current evidence is not clear about the impact of D614G mutation alone on the disease severity and mortality as multiple other stronger factors play role especially age and comorbidity (<xref ref-type="bibr" rid="R50">50</xref>).</p>
<p id="P23">There has been concerns about the impact of D614G mutation on vaccine development but it is clear that the mutation does not take place in the receptor binding region of the spike protein which is the primary target of the neutralizing antibodies. Also, studies suggested that in natural infection, antibodies generated from D614 variant can cross neutralize G614 variant viruses. Hence this is unlikely that the mutation will have a drastic effect on the immunogenicity of the virus and less like to have any impact on vaccine efficacy (<xref ref-type="bibr" rid="R50">50</xref>–<xref ref-type="bibr" rid="R52">52</xref>).</p>
<p id="P24">The second most frequent mutation in our analysis was a tri-nucleotide change resulting in two amino acid changes which are R203 and G204R in N protein. Our analysis revealed these mutations occurred in a PCR target area and B-cell epitope region. Though functionally tolerated this change was predicted to decrease the protein stability. This finding is similar with other studies that reported R203K and G204K destabilizes N protein structure but may enhance interaction with SARS-CoV-2 Envelop protein that may promote viral release (<xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R54">54</xref>).</p>
<p id="P25">The I300F mutation (occurred in 78% isolates) was predicted to reduce the stability of NSP2 protein the function of which is not yet confirmed. One study suggested that the amino acid is positioned within the internal groove of the protein and less likely to interact with host factors (<xref ref-type="bibr" rid="R55">55</xref>). There two other functionally significant mutations which are Q57H in ORF3a and S194L in N protein. Our analysis suggested the Q57H decreases protein stability with altered protein function may result in loss of a CD4+ T Cell epitope similar to other studies (<xref ref-type="bibr" rid="R53">53</xref>,<xref ref-type="bibr" rid="R56">56</xref>). The S194L was predicted to have neutral effect in our study with a reduced DDG value and may attenuate viral assembly as reported in an earlier study (<xref ref-type="bibr" rid="R53">53</xref>).</p>
<p id="P26">We have observed several mutations in some of the RT-PCR target regions. Though it is yet unknown that if mismatch in primer template changes the accuracy and precision of RT-PCR based COVID-19 diagnosis, we recommend avoidance of using primers containing mutation prone regions for better diagnosis.</p>
<p id="P27">As a limitation of our study, we couldn’t derive any clinical information of the patients from whom the samples were collected. The functional significance described in this paper are only computational prediction based and may not always reflect clinical scenario. Also, the genomic sequences were derived using different sequencing platforms (i.e. Illumina, Ion Torrent etc.) and methods (Sanger and Next-generation sequencing) by different laboratories which may have impacted the quality of the sequences hence impacted our analysis. We have found one sequenced that has no mutation compared to the reference sequence which is very unlikely and may possibly be a submission error as the sample was collected long after the original Wuhan outbreak. We hope our findings will create scopes for further research specially including clinical data and also help identifying changes in pathogenicity and infectivity pattern of the virus.</p>
</sec>
<sec sec-type="supplementary-material" id="SM">
<title>Supplementary Material</title>
<supplementary-material content-type="local-data" id="SD1">
<label>Supplementary Figure 1: Phylogeny clusters formed by Bangladeshi isolates</label>
<media xlink:href="EMS98309-supplement-Supplementary_Figure_1__Phylogeny_clusters_formed_by_Bangladeshi_isolates.jpg" mimetype="image" mime-subtype="jpeg" id="N66198" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD2">
<label>Supplementary Table 1. Surface glycoprotein variants with their effect and significance.</label>
<media xlink:href="EMS98309-supplement-Supplementary_Table_1__Surface_glycoprotein_variants_with_their_effect_and_significance_.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="N66207" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD3">
<label>Supplementary Figure 2: Phylogeny clusters formed by Bangladeshi isolates</label>
<media xlink:href="EMS98309-supplement-Supplementary_Figure_2__Phylogeny_clusters_formed_by_Bangladeshi_isolates.jpg" mimetype="image" mime-subtype="jpeg" id="N66216" position="anchor"/>
</supplementary-material>
<supplementary-material content-type="local-data" id="SD4">
<label>Supplementary Figure 3: Phylogeny clusters formed by Bangladeshi isolates</label>
<media xlink:href="EMS98309-supplement-Supplementary_Figure_3__Phylogeny_clusters_formed_by_Bangladeshi_isolates.jpg" mimetype="image" mime-subtype="jpeg" id="N66225" position="anchor"/>
</supplementary-material>
</sec>
</body>
<back>
<ack id="S11">
<title>Acknowledgements</title>
<p>We acknowledge who were involved in the process of sample collection, genome sequencing and sequence data submission in the GISAID database. We also acknowledge Dr. Senjuti Saha, Scientist, Child Health Research Foundation Bangladesh, who inspired and guided us throughout the writing of this article. This study was funded by the Centre for Medical Biotechnology (CMBT), Management Information System, Directorate General of Health Services, Bangladesh.</p>
</ack>
<ref-list>
<ref id="R1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>Yang X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>XG</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title>
<source>Nature</source>
<year>2020</year>
<month>Mar</month>
<day>12</day>
<volume>579</volume>
<issue>7798</issue>
<fpage>270</fpage>
<lpage>3</lpage>
</element-citation>
</ref>
<ref id="R2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019-2020</article-title>
<source>China CDC Weekly</source>
<year>2020</year>
<volume>2</volume>
<issue>4</issue>
<fpage>61</fpage>
<lpage>62</lpage>
<comment>2020 Jan 1;2(4):61–2</comment>
</element-citation>
</ref>
<ref id="R3">
<label>3</label>
<element-citation publication-type="web">
<collab>GISAID-Initiative</collab>
<article-title>GISAID - Initiative</article-title>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/">https://www.gisaid.org/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elbe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buckland-Merrett</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Data, disease and diplomacy: GISAID’s innovative contribution to global health</article-title>
<source>Glob Challenges</source>
<year>2017</year>
<month>Jan</month>
<day>1</day>
<volume>1</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>46</lpage>
<date-in-citation>cited 2020 May 25</date-in-citation>
<comment>[Internet]</comment>
<pub-id pub-id-type="doi">10.1002/gch2.1018</pub-id>
</element-citation>
</ref>
<ref id="R5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khailany</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Safdar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ozaslan</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genomic characterization of a novel SARS-CoV-2</article-title>
<source>Gene Reports</source>
<year>2020</year>
<month>Jun</month>
<day>1</day>
<volume>19</volume>
<comment>100682</comment>
</element-citation>
</ref>
<ref id="R6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forster</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Renfrew</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Forster</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Phylogenetic network analysis of SARS-CoV-2 genomes</article-title>
<source>Proc Natl Acad Sci</source>
<year>2020</year>
<month>Apr</month>
<day>8</day>
<volume>117</volume>
<issue>17</issue>
<comment>202004999</comment>
</element-citation>
</ref>
<ref id="R7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pachetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giudici</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mauro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Storici</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant</article-title>
<source>J Transl Med</source>
<year>2020</year>
<month>Dec</month>
<day>22</day>
<volume>18</volume>
<issue>1</issue>
<fpage>179</fpage>
<date-in-citation>cited 2020 May 9</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02344-6">https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02344-6</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>
<article-title>Patient-derived mutations impact pathogenicity of SARS-CoV-2</article-title>
<source>medRxiv</source>
<year>2020</year>
<month>Apr</month>
<day>23</day>
<comment>2020.04.14.20060160</comment>
</element-citation>
</ref>
<ref id="R9">
<label>9</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Holmes</surname>
<given-names>EC</given-names>
</name>
</person-group>
<article-title>The Evolution and Emergence of RNA Viruses</article-title>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/eid">www.cdc.gov/eid</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armengaud</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delaunay-Moisan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thuret</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anken</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Acosta-Alvear</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aragón</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>The importance of naturally attenuated SARS-CoV-2 in the fight against COVID-19</article-title>
<source>Environ Microbiol</source>
<year>2020</year>
<month>Jun</month>
<day>9</day>
<volume>22</volume>
<issue>6</issue>
<fpage>1997</fpage>
<lpage>2000</lpage>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from</comment>
<pub-id pub-id-type="doi">10.1111/1462-2920.15039</pub-id>
</element-citation>
</ref>
<ref id="R11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pachetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Benedetti</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Giudici</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mauro</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Storici</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>
<article-title>Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant</article-title>
<source>J Transl Med</source>
<year>2020</year>
<month>Apr</month>
<day>22</day>
<volume>18</volume>
<issue>1</issue>
<fpage>179</fpage>
<date-in-citation>cited 2020 Aug 8</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02344-6">https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02344-6</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Islam</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Hoque</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>ASMRU</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Puspo</surname>
<given-names>JA</given-names>
</name>
<etal/>
</person-group>
<article-title>Genomewide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity</article-title>
<source>Sci Rep</source>
<year>2020</year>
<month>Dec</month>
<day>1</day>
<volume>10</volume>
<issue>1</issue>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. 14004</comment>
<pub-id pub-id-type="doi">10.1038/s41598-020-70812-6</pub-id>
</element-citation>
</ref>
<ref id="R13">
<label>13</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>ACK</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>
<chapter-title>Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses</chapter-title>
<source>Trends in Microbiology</source>
<publisher-name>Elsevier Ltd</publisher-name>
<year>2016</year>
<volume>24</volume>
<fpage>490</fpage>
<lpage>502</lpage>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R14">
<label>14</label>
<element-citation publication-type="web">
<collab>IEDCR</collab>
<date-in-citation>cited 2020 May 26</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.iedcr.gov.bd/">https://www.iedcr.gov.bd/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R15">
<label>15</label>
<element-citation publication-type="web">
<collab>Reuters</collab>
<article-title>Bangladesh confirms its first three cases of coronavirus - Reuters</article-title>
<date-in-citation>cited 2020 May 25</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.reuters.com/article/us-health-coronavirus-bangladesh-idUSKBN20V0FS">https://www.reuters.com/article/us-health-coronavirus-bangladesh-idUSKBN20V0FS</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cleemput</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dumon</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Abdool</surname>
<given-names>Karim W</given-names>
</name>
<name>
<surname>Giovanetti</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carlos</surname>
<given-names>Alcantara L</given-names>
</name>
<etal/>
</person-group>
<source>Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes</source>
</element-citation>
</ref>
<ref id="R17">
<label>17</label>
<element-citation publication-type="web">
<article-title>A*STAR-Bioinformatics-Institute. CoVsurver - CoronaVirus Surveillance Server</article-title>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://corona.bii.a-star.edu.sg/">https://corona.bii.a-star.edu.sg/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
<source>Nucleic Acids Res</source>
<year>2003</year>
<month>Jul</month>
<day>1</day>
<volume>31</volume>
<issue>13</issue>
<fpage>3812</fpage>
<lpage>4</lpage>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pejaver</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Urresti</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lugo-Martinez</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pagel</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>GN</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>H-J</given-names>
</name>
<etal/>
</person-group>
<source>MutPred2: inferring the molecular and phenotypic impact of amino acid variants</source>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<pub-id pub-id-type="doi">10.1101/134981</pub-id>
</element-citation>
</ref>
<ref id="R20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Hinrichs</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Clawson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Nassar</surname>
<given-names>LR</given-names>
</name>
<etal/>
</person-group>
<article-title>The UCSC SARS-CoV-2 Genome Browser</article-title>
<source>Nature Research</source>
<year>2020</year>
<volume>52</volume>
<fpage>991</fpage>
<lpage>8</lpage>
<date-in-citation>cited 2020 Oct 11</date-in-citation>
<comment>[Internet]. Nature Genetics</comment>
<pub-id pub-id-type="doi">10.1038/s41588-020-0697-z</pub-id>
</element-citation>
</ref>
<ref id="R21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capriotti</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fariselli</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Casadio</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure</article-title>
<source>Nucleic Acids</source>
<year>2005</year>
<month>Jul</month>
<volume>33</volume>
<issue>SUPPL. 2</issue>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. W306. Available from</comment>
</element-citation>
</ref>
<ref id="R22">
<label>22</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Hadfield</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Megill</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Huddleston</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Callender</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group>
<article-title>Nextstrain: real-time tracking of pathogen evolution</article-title>
<date-in-citation>cited 2020 May 26</date-in-citation>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R23">
<label>23</label>
<element-citation publication-type="web">
<collab>Nextclade</collab>
<article-title>Nextclade</article-title>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://clades.nextstrain.org/">https://clades.nextstrain.org/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R24">
<label>24</label>
<element-citation publication-type="web">
<collab>GISAID-clade</collab>
<article-title>GISAID - Clade and lineage nomenclature aids in genomic epidemiology of active hCoV-19 viruses</article-title>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.gisaid.org/references/statements-clarifications/clade-and-lineage-nomenclature-aids-in-genomic-epidemiology-of-active-hcov-19-viruses/">https://www.gisaid.org/references/statements-clarifications/clade-and-lineage-nomenclature-aids-in-genomic-epidemiology-of-active-hcov-19-viruses/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R25">
<label>25</label>
<element-citation publication-type="web">
<collab>nextstrain-github</collab>
<article-title>ncov/naming_clades.md at master · nextstrain/ncov · GitHub</article-title>
<date-in-citation>cited 2020 Sep 19</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/nextstrain/ncov/blob/master/docs/naming_clades.md">https://github.com/nextstrain/ncov/blob/master/docs/naming_clades.md</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R26">
<label>26</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Siddiqui</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sultana</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Akhter</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>LABOUR MIGRATION FROM BANGLADESH 2018 ACHIEVEMENTS AND CHALLENGES</article-title>
<date-in-citation>cited 2020 Aug 8</date-in-citation>
<comment>[Internet] Available from: <ext-link ext-link-type="uri" xlink:href="https://www.forum-asia.org/uploads/wp/2019/05/Migration-Trend-Analysis-2018-RMMRU.pdf">https://www.forum-asia.org/uploads/wp/2019/05/Migration-Trend-Analysis-2018-RMMRU.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R27">
<label>27</label>
<element-citation publication-type="journal">
<collab>IOM</collab>
<article-title>IOM assists vulnerable returning migrants impacted by the COVID-19 pandemic</article-title>
<source>International Organization for Migration</source>
<date-in-citation>cited 2020 Aug 8</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://bangladesh.iom.int/news/iom-assists-vulnerable-returning-migrants-impacted-covid-19-pandemic">https://bangladesh.iom.int/news/iom-assists-vulnerable-returning-migrants-impacted-covid-19-pandemic</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R28">
<label>28</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Arpaia</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Barton</surname>
<given-names>GM</given-names>
</name>
</person-group>
<chapter-title>Toll-like receptors: Key players in antiviral immunity</chapter-title>
<source>Current Opinion in Virology</source>
<publisher-name>Elsevier B.V</publisher-name>
<year>2011</year>
<volume>1</volume>
<fpage>447</fpage>
<lpage>54</lpage>
<date-in-citation>cited 2020 Aug 11</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R29">
<label>29</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Costela-Ruiz</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Illescas-Montes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Puerta-Puerta</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ruiz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Melguizo-Rodríguez</surname>
<given-names>L</given-names>
</name>
</person-group>
<chapter-title>SARS-CoV-2 infection: The role of cytokines in COVID-19 disease</chapter-title>
<source>Cytokine and Growth Factor Reviews</source>
<publisher-name>Elsevier Ltd</publisher-name>
<year>2020</year>
<date-in-citation>cited 2020 Aug 11</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argyropoulos</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Serrano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group>
<article-title>Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with Outcome and Symptoms</article-title>
<source>Am J Pathol</source>
<year>2020</year>
<month>Jul</month>
<volume>0</volume>
<issue>0</issue>
<date-in-citation>cited 2020 Aug 11</date-in-citation>
<comment>[Internet]</comment>
<pub-id pub-id-type="doi">10.1016/j.ajpath.2020.07.001</pub-id>
</element-citation>
</ref>
<ref id="R31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Bouhaddou</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Obernier</surname>
<given-names>K</given-names>
</name>
<name>
<surname>White</surname>
<given-names>KM</given-names>
</name>
<etal/>
</person-group>
<article-title>A SARS-CoV-2 protein interaction map reveals targets for drug repurposing</article-title>
<source>Nature</source>
<year>2020</year>
<month>Jul</month>
<day>16</day>
<volume>583</volume>
<issue>7816</issue>
<fpage>459</fpage>
<lpage>68</lpage>
</element-citation>
</ref>
<ref id="R32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kopecky-Bromberg</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Martinez-Sobrido</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Palese</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>7a Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cellular Protein Synthesis and Activates p38 Mitogen-Activated Protein Kinase</article-title>
<source>J Virol</source>
<year>2006</year>
<month>Jan</month>
<day>15</day>
<volume>80</volume>
<issue>2</issue>
<fpage>785</fpage>
<lpage>93</lpage>
</element-citation>
</ref>
<ref id="R33">
<label>33</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Addetia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Roychoudhury</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Shrestha</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Loprieno</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>ML</given-names>
</name>
<etal/>
</person-group>
<chapter-title>Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates</chapter-title>
<source>Journal of Clinical Virology</source>
<publisher-name>Elsevier B.V</publisher-name>
<year>2020</year>
<volume>129</volume>
<comment>104523</comment>
</element-citation>
</ref>
<ref id="R34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>
<article-title>The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>May</month>
<day>24</day>
<date-in-citation>cited 2020 Aug 12</date-in-citation>
<comment>[Internet]. 2020.05.24.111823 Available from: <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.05.24.111823v1">https://www.biorxiv.org/content/10.1101/2020.05.24.111823v1</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercatelli</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Giorgi</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>Geographic and Genomic Distribution of SARS-CoV-2 Mutations</article-title>
<source>Front Microbiol</source>
<year>2020</year>
<month>Jul</month>
<day>22</day>
<volume>11</volume>
<fpage>1800</fpage>
<date-in-citation>cited 2020 Aug 19</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/article/10.3389/fmicb.2020.01800/full">https://www.frontiersin.org/article/10.3389/fmicb.2020.01800/full</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lon</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Evolution and molecular characteristics of SARS-CoV-2 genome</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>Jun</month>
<day>30</day>
<date-in-citation>cited 2020 Aug 19</date-in-citation>
<comment>[Internet]. 2020.04.24.058933</comment>
<pub-id pub-id-type="doi">10.1101/2020.04.24.058933</pub-id>
</element-citation>
</ref>
<ref id="R37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demir</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Benvenuto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Abacioglu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Angeletti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ciccozzi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey</article-title>
<source>Turkish J Biol</source>
<year>2020</year>
<volume>44</volume>
<issue>Special issue 1</issue>
<fpage>178</fpage>
<lpage>84</lpage>
<date-in-citation>cited 2020 Aug 16</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Begum</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Thagriki</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>AK</given-names>
</name>
<etal/>
</person-group>
<article-title>Specific mutations in SARS-CoV2 RNA dependent RNA polymerase and helicase alter protein structure, dynamics and thus function: Effect on viral RNA replication</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>Apr</month>
<day>27</day>
<date-in-citation>cited 2020 Aug 24</date-in-citation>
<comment>[Internet]. 2020.04.26.063024</comment>
<pub-id pub-id-type="doi">10.1101/2020.04.26.063024</pub-id>
</element-citation>
</ref>
<ref id="R39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eskier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Karakülah</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Suner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oktay</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>RdRp mutations are associated with SARS-CoV-2 genome evolution</article-title>
<source>PeerJ</source>
<year>2020</year>
<month>Jul</month>
<day>21</day>
<volume>8</volume>
<fpage>e9587</fpage>
<date-in-citation>cited 2020 Aug 16</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Theiler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abfalterer</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>May</month>
<day>5</day>
<volume>4</volume>
<date-in-citation>cited 2020 Aug 20</date-in-citation>
<comment>[Internet]. 2020.04.29.069054</comment>
<pub-id pub-id-type="doi">10.1101/2020.04.29.069054</pub-id>
</element-citation>
</ref>
<ref id="R41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Gnanakaran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Theiler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Abfalterer</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group>
<article-title>Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus</article-title>
<source>Cell</source>
<year>2020</year>
<volume>182</volume>
<fpage>812</fpage>
<lpage>827.e19</lpage>
<date-in-citation>cited 2020 Aug 20</date-in-citation>
<comment>[Internet]</comment>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.06.043</pub-id>
</element-citation>
</ref>
<ref id="R42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ojha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rangarajan</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Izard</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group>
<article-title>The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity</article-title>
<source>bioRxiv Prepr Serv Biol</source>
<year>2020</year>
<date-in-citation>cited 2020 Aug 22</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
<ref id="R43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Belouzard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Whittaker</surname>
<given-names>GR</given-names>
</name>
</person-group>
<article-title>Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites</article-title>
<source>Proc Natl Acad Sci U S A</source>
<year>2009</year>
<month>Apr</month>
<day>7</day>
<volume>106</volume>
<issue>14</issue>
<fpage>5871</fpage>
<lpage>6</lpage>
<date-in-citation>cited 2020 Aug 20</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/cgi/content/full/">www.pnas.org/cgi/content/full/</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Majumder</surname>
<given-names>PP</given-names>
</name>
<etal/>
</person-group>
<article-title>Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>May</month>
<day>5</day>
<date-in-citation>cited 2020 Aug 20</date-in-citation>
<comment>[Internet]. 2020.05.04.075911</comment>
<pub-id pub-id-type="doi">10.1101/2020.05.04.075911</pub-id>
</element-citation>
</ref>
<ref id="R45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Andolfo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Alessandro</surname>
<given-names>Lasorsa V</given-names>
</name>
<name>
<surname>Iolascon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Capasso</surname>
<given-names>M</given-names>
</name>
</person-group>
<source>Genetic analysis of the novel SARS-CoV-2 host receptor TMPRSS2 in different populations</source>
<date-in-citation>cited 2020 Aug 20</date-in-citation>
<pub-id pub-id-type="doi">10.1101/2020.04.23.057190</pub-id>
</element-citation>
</ref>
<ref id="R46">
<label>46</label>
<element-citation publication-type="web">
<collab>rs35074065 RefSNP Report - dbSNP - NCBI</collab>
<date-in-citation>cited 2020 Aug 20</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/snp/rs35074065#frequency_tab">https://www.ncbi.nlm.nih.gov/snp/rs35074065#frequency_tab</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toyoshima</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nemoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kiyotani</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 genomic variations associated with mortality rate of COVID-19</article-title>
<source>J Hum Genet</source>
<year>2020</year>
<month>Jul</month>
<day>22</day>
<fpage>1</fpage>
<lpage>8</lpage>
<date-in-citation>cited 2020 Aug 8</date-in-citation>
<comment>[Internet]</comment>
<pub-id pub-id-type="doi">10.1038/s10038-020-0808-9</pub-id>
</element-citation>
</ref>
<ref id="R48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becerra-Flores</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cardozo</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate</article-title>
<source>Int J Clin Pract</source>
<year>2020</year>
<month>Aug</month>
<day>3</day>
<volume>74</volume>
<issue>8</issue>
<date-in-citation>cited 2020 Aug 22</date-in-citation>
<comment>[Internet]. Available from</comment>
<pub-id pub-id-type="doi">10.1111/ijcp.13525</pub-id>
</element-citation>
</ref>
<ref id="R49">
<label>49</label>
<element-citation publication-type="web">
<person-group person-group-type="author">
<name>
<surname>Wagner</surname>
<given-names>Cassia</given-names>
</name>
<name>
<surname>Roychoudhury</surname>
<given-names>Pavitra</given-names>
</name>
<name>
<surname>Frazar</surname>
<given-names>Chris D</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Jover</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>Nicola F</given-names>
</name>
<name>
<surname>Moncla</surname>
<given-names>Louise H</given-names>
</name>
<etal/>
</person-group>
<article-title>Comparing viral load and clinical outcomes in Washington State across D614G substitution in spike protein of SARS-CoV-2</article-title>
<date-in-citation>cited 2020 Aug 22</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/blab/ncov-wa-d614g">https://github.com/blab/ncov-wa-d614g</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grubaugh</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Hanage</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>AL</given-names>
</name>
</person-group>
<source>Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear</source>
<year>2020</year>
<date-in-citation>cited 2020 Aug 22</date-in-citation>
<pub-id pub-id-type="doi">10.1016/j.cell.2020.06.040</pub-id>
</element-citation>
</ref>
<ref id="R51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozono</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ode</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Seng</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyoshi</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>
<article-title>Naturally mutated spike proteins of SARS-CoV-2 variants show differential levels of cell entry</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>Jun</month>
<day>26</day>
<date-in-citation>cited 2020 Aug 22</date-in-citation>
<comment>[Internet]. 2020.06.15.151779. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.gisaid.org">www.gisaid.org</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>He</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>XX</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>QX</given-names>
</name>
<etal/>
</person-group>
<article-title>The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera</article-title>
<source>bioRxiv</source>
<year>2020</year>
<month>Jul</month>
<day>6</day>
<date-in-citation>cited 2020 Aug 22</date-in-citation>
<comment>[Internet]. 2020.06.20.161323. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.06.20.161323v1">https://www.biorxiv.org/content/10.1101/2020.06.20.161323v1</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X</given-names>
</name>
<etal/>
</person-group>
<source>Effects of SARS-CoV-2 Mutations on Protein Structures and Intraviral Protein-Protein Interactions</source>
<date-in-citation>cited 2020 Aug 24</date-in-citation>
<pub-id pub-id-type="doi">10.1101/2020.08.15.241349</pub-id>
</element-citation>
</ref>
<ref id="R54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rahman</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Rafiul</surname>
<given-names>Islam M</given-names>
</name>
<name>
<surname>Rubayet</surname>
<given-names>ASM</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hoque</surname>
<given-names>MN</given-names>
</name>
<etal/>
</person-group>
<article-title>Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein (N protein) and its consequences</article-title>
<source>bioRxiv Cold Spring Harbor Laboratory</source>
<year>2020</year>
<month>Aug</month>
<date-in-citation>cited 2020 Aug 24</date-in-citation>
<comment>[Internet]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.08.05.237339v1">https://www.biorxiv.org/content/10.1101/2020.08.05.237339v1</ext-link>
</comment>
</element-citation>
</ref>
<ref id="R55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ul Alam</surname>
<given-names>ASMR</given-names>
</name>
<name>
<surname>Rafiul</surname>
<given-names>Islam M</given-names>
</name>
<name>
<surname>Shaminur</surname>
<given-names>Rahman M</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>OK</given-names>
</name>
<name>
<surname>Anwar</surname>
<given-names>Hossain M</given-names>
</name>
</person-group>
<article-title>Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain</article-title>
<source>J Med Virol</source>
<year>2020</year>
<month>Jun</month>
<day>3</day>
<date-in-citation>cited 2020 Aug 24</date-in-citation>
<comment>[Internet]. jmv.26115. Available from</comment>
<pub-id pub-id-type="doi">10.1002/jmv.26115</pub-id>
</element-citation>
</ref>
<ref id="R56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J-S</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>FS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J-M</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>Y-S</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>C-K</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>M-G</given-names>
</name>
</person-group>
<article-title>Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome</article-title>
<source>Osong Public Heal Res Perspect</source>
<year>2020</year>
<month>Jun</month>
<day>30</day>
<volume>11</volume>
<issue>3</issue>
<fpage>101</fpage>
<lpage>11</lpage>
<date-in-citation>cited 2020 Aug 24</date-in-citation>
<comment>[Internet]. Available from</comment>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<title>(a) Frequency of SNVs along the base positions of SARS-CoV-2 genome with high frequency (&gt;5) missense SNVs marked red (b) The high frequency missense SNVs aligned (red lines) to different regions of SARS-CoV-2 genome, uniport regions of interest, RT-PCR diagnostic primer set, B-Cell and T-Cell predicted epitope regions, SARS-CoV T Cell epitope regions (M1 and M2 peptides), human protein interaction, protease cleavage and signal peptide regions derived from UCSC genome browser.</title>
</caption>
<graphic xlink:href="EMS98309-f001"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<title>(a) Frequency of SNVs along the base positions of SARS-CoV-2 S gene, missense mutations are annotated in red text (b) The missense SNVs aligned (red lines) to different regions of SARS-CoV-2 S gene, uniport regions of interest, RT-PCR diagnostic primer set, B-Cell and T-Cell predicted epitope regions, SARS-CoV T Cell epitope regions (M1 and M2 peptides), human protein interaction, protease cleavage and signal peptide regions derived from UCSC genome browser.</title>
</caption>
<graphic xlink:href="EMS98309-f002"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<title>(A) Mutated amino acid positions shown in the unbound structure of SARS-CoV-2 spike protein (except L5F, S13I, Q14H, R1185H and K1195N). (B) Mutated amino acid positions shown in the human ACE2 receptor (marked in green) bound structure of SARS-CoV-2 spike protein (except L5F, S13I, Q14H, R1185H and K1195N).</title>
</caption>
<graphic xlink:href="EMS98309-f003"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<title>Radial presentation of phylogeny tree formed from 324 SARS-CoV-2 genomes from Bangladesh compared to the reference SARS-CoV-2 sequence shows the isolates belonged to all of the nextstrain clades and the 20B clade is the most prominent.</title>
</caption>
<graphic xlink:href="EMS98309-f004"/>
</fig>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<title>Comparison of clade distribution in different regions of Asia from subsampled global analysis in nextrain.org</title>
</caption>
<graphic xlink:href="EMS98309-f005"/>
</fig>
<table-wrap id="T1" position="float" orientation="portrait">
<label>Table 1</label>
<caption>
<title>Distribution of mutation events along different genomic regions of SARS-CoV-2 Bangladeshi isolates.</title>
</caption>
<table frame="above" rules="groups">
<thead>
<tr>
<th align="left" valign="top" colspan="2">Genome segment<xref ref-type="table-fn" rid="TFN1">*</xref>
</th>
<th align="left" valign="top">Base Position</th>
<th align="left" valign="top">Total mutation</th>
<th align="left" valign="top">Missense Mutation</th>
<th align="left" valign="top">Synonymous Mutation</th>
<th align="left" valign="top">Deletion<xref ref-type="table-fn" rid="TFN1">**</xref>
</th>
<th align="left" valign="top">Insertion</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Coding region</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="left" valign="top">266-21555</td>
<td align="left" valign="top">1796</td>
<td align="left" valign="top">1021</td>
<td align="left" valign="top">775</td>
<td align="left" valign="top">2</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>S</italic>
</td>
<td align="left" valign="top">21563-25384</td>
<td align="left" valign="top">528</td>
<td align="left" valign="top">416</td>
<td align="left" valign="top">112</td>
<td align="left" valign="top">3</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>ORF3a</italic>
</td>
<td align="left" valign="top">25393-26220</td>
<td align="left" valign="top">135</td>
<td align="left" valign="top">101</td>
<td align="left" valign="top">34</td>
<td align="left" valign="top">7</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>E</italic>
</td>
<td align="left" valign="top">26245-26472</td>
<td align="left" valign="top">4</td>
<td align="left" valign="top">3</td>
<td align="left" valign="top">1</td>
<td align="left" valign="top">0</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>M</italic>
</td>
<td align="left" valign="top">26523-27191</td>
<td align="left" valign="top">65</td>
<td align="left" valign="top">14</td>
<td align="left" valign="top">51</td>
<td align="left" valign="top">0</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>ORF6</italic>
</td>
<td align="left" valign="top">27202-27387</td>
<td align="left" valign="top">8</td>
<td align="left" valign="top">6</td>
<td align="left" valign="top">2</td>
<td align="left" valign="top">1</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>ORF7a</italic>
</td>
<td align="left" valign="top">27394-27759</td>
<td align="left" valign="top">50</td>
<td align="left" valign="top">9</td>
<td align="left" valign="top">41</td>
<td align="left" valign="top">9</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>ORF7b</italic>
</td>
<td align="left" valign="top">27756-27887</td>
<td align="left" valign="top">8</td>
<td align="left" valign="top">5</td>
<td align="left" valign="top">3</td>
<td align="left" valign="top">0</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>ORF8</italic>
</td>
<td align="left" valign="top">27894-28259</td>
<td align="left" valign="top">70</td>
<td align="left" valign="top">34</td>
<td align="left" valign="top">36</td>
<td align="left" valign="top">2</td>
<td align="left" valign="top">0</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>N</italic>
</td>
<td align="left" valign="top">28274-29533</td>
<td align="left" valign="top">949</td>
<td align="left" valign="top">635</td>
<td align="left" valign="top">314</td>
<td align="left" valign="top">0</td>
<td align="left" valign="top">3</td>
</tr>
<tr style="border-bottom: solid thin">
<td align="left" valign="top"/>
<td align="left" valign="top">
<italic>ORF10</italic>
</td>
<td align="left" valign="top">29558-29674</td>
<td align="left" valign="top">13</td>
<td align="left" valign="top">0</td>
<td align="left" valign="top">13</td>
<td align="left" valign="top">0</td>
<td align="left" valign="top">2</td>
</tr>
<tr>
<td align="left" valign="top">Non-coding region</td>
<td align="left" valign="top">Intergenic</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">12</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">2</td>
<td align="left" valign="top">1</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">5’-UTR</td>
<td align="left" valign="top">1-265</td>
<td align="left" valign="top">386</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">5</td>
<td align="left" valign="top">1</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">3’-UTR</td>
<td align="left" valign="top">29675-29903</td>
<td align="left" valign="top">136</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">-</td>
<td align="left" valign="top">7</td>
<td align="left" valign="top">3</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">
<bold>Total</bold>
</td>
<td align="left" valign="top"/>
<td align="left" valign="top">
<bold>4160</bold>
</td>
<td align="left" valign="top">
<bold>2253</bold>
</td>
<td align="left" valign="top">
<bold>1382</bold>
</td>
<td align="left" valign="top">
<bold>38<xref ref-type="table-fn" rid="TFN1">**</xref>
</bold>
</td>
<td align="left" valign="top">
<bold>10</bold>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TFN1">
<p id="P28">
<bold>*Genes in displayed in italics, **Some deletion events continued over multiple regions</bold>
</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float" orientation="portrait">
<label>Table 2</label>
<caption>
<title>Variants of SARS-CoV-2 genomes observed in more than 5 isolates</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" valign="top">Genomic change</th>
<th align="left" valign="top">Type of mutation</th>
<th align="left" valign="top">Gene</th>
<th align="center" valign="top">Amino acid change</th>
<th align="left" valign="top">No. of samples</th>
<th align="center" valign="top">Structural Prediction Effect (SVM3)</th>
<th align="center" valign="top">DDG Value (kcal/mol)</th>
<th align="center" valign="top">Functional prediction Effect</th>
<th align="center" valign="top">Predicted molecular mechanism change</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">
<bold>241C &gt; T</bold>
</td>
<td align="left" valign="top">Non-coding</td>
<td align="left" valign="top">
<italic>5’-UTR</italic>
</td>
<td align="center" valign="top">-</td>
<td align="left" valign="top">312</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>683C&gt;T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>1163A &gt; T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">I300F</td>
<td align="left" valign="top">255</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-1.79</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">CD4+ T Cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>2040C&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">T592I</td>
<td align="left" valign="top">12</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">-0.48</td>
<td align="center" valign="top">Affect function</td>
<td align="center" valign="top">CD8+ T Cell epitope (strong prediction)</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>2388C&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">T708I</td>
<td align="left" valign="top">11</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">-0.35</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">CD4+ and CD8+ T Cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>2836C&gt;T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">6</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>2910C&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">T882I</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">-0.10</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>3037C &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">318</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>3961C &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">38</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>4444G &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">7</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>8026A&gt;G</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">17</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>8371G&gt; T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">Q2702H</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.68</td>
<td align="center" valign="top">Affect function</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>9502C&gt;T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">7</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>10323A&gt;G</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">K3353R</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">-0.13</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">CD4+ T Cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>11083G&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">L3606F</td>
<td align="left" valign="top">11</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-1.00</td>
<td align="center" valign="top">Affect function</td>
<td align="center" valign="top">Altered Ordered interface, Altered Transmembrane protein, Gain of Sulfation at Y3607, CD4+ and CD8+ T Cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>14408C&gt; T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">P4715L</td>
<td align="left" valign="top">317</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.83</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">CD8+ T Cell epitope, RdRp zone,</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>15324C &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>15738C&gt;T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">7</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>18877C&gt;T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">24</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>19723G&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORFlab</italic>
</td>
<td align="center" valign="top">V6487F</td>
<td align="left" valign="top">17</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-1.55</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>21575C&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>S</italic>
</td>
<td align="center" valign="top">L5F</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.98</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>21855C&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>S</italic>
</td>
<td align="center" valign="top">S98F</td>
<td align="left" valign="top">6</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">0.00</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>22444C &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>S</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">24</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>23403A &gt; G</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>S</italic>
</td>
<td align="center" valign="top">D614G</td>
<td align="left" valign="top">315</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.93</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">B cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>25494G &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>ORF3a</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">19</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>25504C&gt;G</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORF3a</italic>
</td>
<td align="center" valign="top">Q38E</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-1.02</td>
<td align="center" valign="top">Affect function</td>
<td align="center" valign="top">CD4+ and CD8+ T Cell epitope, transmembrane protein</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>25563G &gt; T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>ORF3a</italic>
</td>
<td align="center" valign="top">Q57H</td>
<td align="left" valign="top">30</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-2.03</td>
<td align="center" valign="top">Affect function</td>
<td align="center" valign="top">CD4+ T Cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>26735C &gt; T</bold>
</td>
<td align="left" valign="top">Synonymous</td>
<td align="left" valign="top">
<italic>M</italic>
</td>
<td align="center" valign="top">None</td>
<td align="left" valign="top">29</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>26895C&gt;T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>M</italic>
</td>
<td align="center" valign="top">H125Y</td>
<td align="left" valign="top">6</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">0.06</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">CD8+ T Cell epitope, Altered Transmembrane protein Altered Ordered interface</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>28854C &gt; T</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>N</italic>
</td>
<td align="center" valign="top">S194L</td>
<td align="left" valign="top">25</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">-0.38</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">B cell epitope</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>28881G&gt; A</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>N</italic>
</td>
<td align="center" valign="top">R203K</td>
<td align="left" valign="top">279</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.93</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">B cell epitope, PCR target area, transmembrane protein</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>28882G&gt;A</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>N</italic>
</td>
<td align="center" valign="top">R203K</td>
<td align="left" valign="top">279</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.93</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">B cell epitope, PCR target area, transmembrane protein</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>28883G &gt; C</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>N</italic>
</td>
<td align="center" valign="top">G204R</td>
<td align="left" valign="top">279</td>
<td align="center" valign="top">Decrease</td>
<td align="center" valign="top">-0.52</td>
<td align="center" valign="top">Affect function</td>
<td align="center" valign="top">B cell epitope, PCR target area, transmembrane protein</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>29403A &gt; G</bold>
</td>
<td align="left" valign="top">Missense</td>
<td align="left" valign="top">
<italic>N</italic>
</td>
<td align="center" valign="top">D377G</td>
<td align="left" valign="top">6</td>
<td align="center" valign="top">Neutral</td>
<td align="center" valign="top">-0.44</td>
<td align="center" valign="top">Tolerated</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>29742G &gt; A</bold>
</td>
<td align="left" valign="top">Non-coding</td>
<td align="left" valign="top">
<italic>3’-UTR</italic>
</td>
<td align="center" valign="top">-</td>
<td align="left" valign="top">7</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>29848T&gt;A</bold>
</td>
<td align="left" valign="top">Non-coding</td>
<td align="left" valign="top">
<italic>3’-UTR</italic>
</td>
<td align="center" valign="top">-</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>29850A&gt;T</bold>
</td>
<td align="left" valign="top">Non-coding</td>
<td align="left" valign="top">
<italic>3’-UTR</italic>
</td>
<td align="center" valign="top">-</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>29852A &gt; T</bold>
</td>
<td align="left" valign="top">Non-coding</td>
<td align="left" valign="top">
<italic>3’-UTR</italic>
</td>
<td align="center" valign="top">-</td>
<td align="left" valign="top">7</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
<tr>
<td align="left" valign="top">
<bold>29853G &gt; A</bold>
</td>
<td align="left" valign="top">Non-coding</td>
<td align="left" valign="top">
<italic>3’-UTR</italic>
</td>
<td align="center" valign="top">-</td>
<td align="left" valign="top">8</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
<td align="center" valign="top">-</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T3" position="float" orientation="portrait">
<label>Table 3</label>
<caption>
<title>Location-wise of distribution of isolates from different clades (<xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref>)</title>
</caption>
<table frame="box" rules="all">
<thead>
<tr>
<th align="left" valign="top">Location (Division)</th>
<th align="left" valign="top">Nextstrain/GISAID Clade</th>
<th align="left" valign="top">No. of Isolates</th>
<th align="left" valign="top">Primary Countries</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="3">Dhaka</td>
<td align="left" valign="top">19A/L</td>
<td align="left" valign="top">1/1</td>
<td align="left" valign="top">Asia: China/Thailand</td>
</tr>
<tr>
<td align="left" valign="top">20A/G,GH</td>
<td align="left" valign="top">6/5,1</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/GR,O</td>
<td align="left" valign="top">77/75,2</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="3">Chittagong</td>
<td align="left" valign="top">19B/S</td>
<td align="left" valign="top">5/5</td>
<td align="left" valign="top">Asia: China</td>
</tr>
<tr>
<td align="left" valign="top">20A/G,GH,O</td>
<td align="left" valign="top">14/2,11,1</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/GR</td>
<td align="left" valign="top">55/55</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Rajshahi</td>
<td align="left" valign="top">20A/GH</td>
<td align="left" valign="top">2/2</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/GR</td>
<td align="left" valign="top">30/30</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Rangpur</td>
<td align="left" valign="top">20A/GH</td>
<td align="left" valign="top">1/1</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/GR,G</td>
<td align="left" valign="top">24/23,1</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Khulna</td>
<td align="left" valign="top">20A/O,GH</td>
<td align="left" valign="top">5/3,2</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/GR</td>
<td align="left" valign="top">22/22</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Sylhet</td>
<td align="left" valign="top">20A/GH</td>
<td align="left" valign="top">2/2</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/GR</td>
<td align="left" valign="top">19/19</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Barishal</td>
<td align="left" valign="top">20A/GH</td>
<td align="left" valign="top">2/2</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top">20B/G,GR</td>
<td align="left" valign="top">21/1,20</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top">Unknown</td>
<td align="left" valign="top">20A/G,GH</td>
<td align="left" valign="top">6/4,2</td>
<td align="left" valign="top">N America/Europe/Asia: USA, Belgium, India</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">20B/GR</td>
<td align="left" valign="top">16/16</td>
<td align="left" valign="top">Europe: UK, Belgium, Sweden</td>
</tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">20C/GH</td>
<td align="left" valign="top">1/1</td>
<td align="left" valign="top">N America: USA</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
